跳至主要内容
临床试验/NCT01339208
NCT01339208已完成不适用

TREAT (Telemedicine for Reach, Education, Access, and Treatment)

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Change in HbA1c % from baseline

研究概览

简要总结

The purpose of this study is to evaluate the feasibility and clinical efficacy of an innovative care model that combines Telemedicine consultations, educator therapeutic management and diabetes education to empower patients to be in greater control of their own diabetes care for improvements in diabetes outcomes.

详细描述

This study will assess whether a new care delivery model combining telemedicine videoconference diabetes consultations with diabetes self-management teaching is efficacious in reducing HbA1c in patients with type 2 diabetes in rural areas. The control group will consist of patients with type 2 diabetes receiving "usual care", i.e., who have not received a referral to the endocrinologist telemedicine team. Secondary outcomes include patient satisfaction, level of understanding of self-management skills, and hypoglycemia

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older with type 2 diabetes
  • Referral by a primary care provider.
  • HbA1c equal or greater than 7.0%.

排除标准

  • Type 1 diabetes
  • Gestational Diabetes

结局指标

主要结局

Change in HbA1c % from baseline

时间窗: 3 and 6 month

次要结局

  • Patient satisfaction(6 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Linda Siminerio

Director Diabetes Institute

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验

TREAT (Telemedicine for Reach, Education, Access,... | 临床试验